alpha-monofluoromethyldopa has been researched along with Hypertension in 1 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fozard, JR; Koch-Weser, J; Möhring, J; Palfreyman, MG; Spedding, M; Wagner, J | 1 |
1 other study(ies) available for alpha-monofluoromethyldopa and Hypertension
| Article | Year |
|---|---|
Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Dopamine; Hypertension; Male; Methyldopa; Neurotransmitter Agents; Rats; Reserpine; Spinal Cord; Sympathetic Nervous System | 1980 |